amgen glp 1 Development Progress and Prospects of Antibody-Peptide Conjugates Amgen playing in the GLP-1

A breakout above recent highs could attract additional momentum-driven buying

It was identified before GLP-1 and was actually the first incretin hormone described in the literature

Key takeaways Wegovy is a glucagon-like peptide-1 (GLP-1) agonist available in a weekly injection or daily tablet

The effects of exogenous GLP-1 after administration to T2DM patients show improved insulin sensitivity, decreased glucagon concentration, slowed gastric emptying, increased satiety, decreased fatty acid concentration, lowered body weight, and overall decreased hemoglobin A1c (HBA1c) levels

GLP-1 medications might help you manage your weight or blood sugar, but not without potentially also affecting how you manage bipolar disorder

While this is certainly a reasonable concern, we view the FDAs decision on Bydureon as excessive, given the lack of any signal for a cardiovascular safety issue and the amount of data already submitted